Search Orphan Drug Designations and Approvals
-
Generic Name: | pegcetacoplan |
---|---|
Date Designated: | 06/07/2022 |
Orphan Designation: | Treatment of immune complex-membranoproliferative glomerulonephritis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Apellis Pharmaceuticals, Inc. 100 5th Ave 3rd floor Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-